Wikidata

(Q33215194)

English

Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors

scientific article

In more languages

Statements

title
Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15897580
retrieved
24 July 2017
author name string
Maja J A de Jonge
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15897580
retrieved
24 July 2017
Ate van der Gaast
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15897580
retrieved
24 July 2017
André S T Planting
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15897580
retrieved
24 July 2017
Leny van Doorn
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15897580
retrieved
24 July 2017
Jantien Wanders
series ordinal
7
1 reference
stated in
Europe PubMed Central
PubMed ID
15897580
retrieved
24 July 2017
Masahiko Satomi
series ordinal
8
1 reference
stated in
Europe PubMed Central
PubMed ID
15897580
retrieved
24 July 2017
page(s)
3806-3813
1 reference
stated in
Europe PubMed Central
PubMed ID
15897580
retrieved
24 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33215194&oldid=1961851417"